Barely Significant

Excerpts

514,629 sentences

borderline significantp > .051.0× alphagold
According to the analysis: Structure: C (2.32) > B (2.21) > A (1.98)— p = .044*, Activity: C (0.91) > A (0.49)— p = .068 (borderline significant), Freedom: C/B (2.13) > A (1.84)— p > .05, Other Factors: No significant difference between groups in Privacy, Emotional Feedback, Support, and Social Interaction ( p > .05).
highly significantp values <0.051.0× alphaqualifiedgold
87 , 88 , 89 A p ‐value less than 0.05 and 0.01 indicates that the model terms are statistically significant at the 95% confidence level and are highly significant at the 99% confidence level. 90 , 91 , 92 Thus, p values <0.05 obtained from ANOVA were considered statistically significant.
borderline significancep = 0.051.0× alpha
Limited access to dental care showed borderline significance (aOR = 2.10; 95% CI: 1.01–4.38; p = 0.05), whereas other variables such as prosthetic heart valves 9(aOR = 2.05, 95% CI: 0.74–5.67) and prior antibiotic use aOR = 1.35, 95% CI: 0.64–2.86) had elevated point estimates but did not remain significant after adjustment.
weakly significantp < 0.051.0× alphaqualifiedgold
However, no significant relationship was found between the helpless approach and the submissive approach and the total needs score, and only a weakly significant relationship was found with the support sub-dimension ( r =-0.109, p < 0.05 for the helpless approach; r = 0.105, p < 0.05 for the submissive approach).
approaching significancep ≈ 0.051.0× alphagold
Expression and validation of biomarkers To validate biomarker expression patterns, Wilcoxon rank-sum tests revealed that in biomarker set 1, both BID and NDUFB6 were significantly downregulated in COPD and NSCLC with COPD groups compared to controls, while PRDX5 showed no significant difference in COPD (though approaching significance, p ≈ 0.05) but was significantly reduced in NSCLC with COPD ( Figures 9 A and 9B); for biomarker set 2, all five biomarkers exhibited significant differential expression in NSCLC versus controls ( Figure 9 C), whereas in NSCLC with COPD only UQCR11 reached significance with the other four biomarkers approaching the threshold ( p ≈ 0.05) ( Figure 9 D).